Michael F Holick

This inventor holds 31 USPTO granted patents and 6 published patent applications, primarily in Vitamin D Research. Top assignees: The General Hospital Corporation, Boston University, A & D Bioscience, Inc.. Active years: 1980-2011.

USPTO Granted Patents = 31 (Patent Applications = 6)

% Patents Active = 90.3

Average Co-Inventor Count = 1.4

ph-index = 15

Forward Citations = 648(Granted Patents)

Location History:

Sudbary, MA (US) (1991)
Sudbury, MA (US) (1980 - 2011)

Company Filing History:

9 out of 3,071

The General Hospital Corporation

A & D Bioscience, Inc.

patents

4. 2 out of 5,024

Hoffmann-La Roche Inc.

A and D Assay, Incorporated

patent

7. 8 out of 834,453

Other

patents

Years Active: 1980-2011

Loading Chart...

Areas of Expertise:

Vitamin D Compounds

Androgen Derivatives

Cell Proliferation

Vaginal Atrophy

Skin Growth

Emu Oil

Peptide Regulation

Psoriasis Treatment

Sunscreen Agents

Vitamin Glycosides

Hormonal Treatments

Therapeutic Compositions

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7906480 - Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy (2011-03-15),

2. 7217696 - Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof (2007-05-15),

3. 6916791 - Androgen derivatives and uses thereof (2005-07-12),

4. 6630453 - Androgen derivatives and uses thereof (2003-10-07),

5. 6455714 - Labeled vitamin D compounds and the use thereof (2002-09-24),

6. 6291693 - Kits comprising labeled vitamin D compounds (2001-09-18),

7. 6066618 - Regulation of cell proliferation and differentiation using peptides (2000-05-23),

8. 5981779 - Labeled vitamin D compounds and the use thereof (1999-11-09),

9. 5958384 - Use of emu oil for stimulating skin and hair growth (1999-09-28),

10. 5840690 - Regulation of cell proliferation and differentation using peptides (1998-11-24),

11. 5744128 - Use of emu oil for stimulating skin and hair growth (1998-04-28),

12. 5612317 - Method for delivering estrogen (1997-03-18),

13. 5527772 - Regulation of cell proliferation and differentiation using peptides (1996-06-18),

14. 5508392 - Use of vitamin D glycosides, vitamin D orthoester glycosides, vitamin D (1996-04-16),

15. 5422099 - Compositions comprising vitamin D precursors and the use thereof (1995-06-06),

Title: Innovations and Contributions of Michael F. Holick

Introduction

Michael F. Holick, based in Sudbury, Massachusetts, is a prolific inventor with a remarkable portfolio of 31 patents. His work predominantly focuses on advancements in the field of medical treatments, specifically targeting conditions that significantly impact quality of life.

Latest Patents

Among his latest innovations, Holick has developed two notable patents. The first involves the use of parathyroid hormone peptide analogs for the treatment of vaginal atrophy. This invention outlines methods for treating this condition by administering a parathyroid hormone peptide or its analog, improving the lives of many women facing this issue. The second patent focuses on glycuronamides, glycosides, and orthoester glycosides of fluoxetine and their analogs. This invention presents a new approach to treating conditions such as depression, showcasing Holick's commitment to addressing critical health challenges.

Career Highlights

Holick has made significant contributions to the scientific community, leveraging his expertise in endocrinology and pharmacology. His career is marked by innovation and dedication to improving health outcomes through his inventions, which resonate strongly in the pharmaceutical and medical fields.

Collaborations

Throughout his career, Holick has collaborated with notable colleagues including Sally A. Holick and Rahul Ray. These partnerships have enhanced his research capabilities and contributed to the successful development of his patented innovations.

Conclusion

Michael F. Holick stands out as a distinguished inventor whose contributions to medicine significantly enhance the understanding and treatment of various health conditions. His portfolio of patents not only reflects his dedication to innovation but also demonstrates the impactful nature of collaboration in advancing scientific knowledge and improving patient care.